Clinical Trials Browser

Phase 1/2 × Rectal Neoplasms × Ipilimumab × Clear all

NCT02948348 2021-09-16

Study to Nivolumab Following Preoperative Chemoradiotherapy

Phase 1/2 Unknown

Gastrointestinal

Rectal Neoplasms